Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-12-20 6:05 pm Sale | 13D | COSCIENS Biopharma Inc. CSCI | Goodwood Inc. | 0 0.000% | -221,570 (Position Closed) | View |
| 2024-09-06 2:04 pm Purchase | 13D | COSCIENS Biopharma Inc. CSCI | Goodwood Inc. | 221,570 7.200% | 221,570 (New Position) | View |
| 2024-06-06 1:46 pm Purchase | 13G | COSCIENS Biopharma Inc. CSCI | Goodwood Inc. | 225,150 7.200% | 225,150 (New Position) | View |
| 2022-02-11 5:03 pm Sale | 13G | COSCIENS Biopharma Inc. CSCI | Lind Global Macro Fund LP | 2,421,512 2.000% | -2,000,000 (-45.23%) | View |
| 2022-02-11 06:41 am Sale | 13G | COSCIENS Biopharma Inc. CSCI | INTRACOASTAL CAPITAL LLC | 289,856 0.200% | -3,263,925 (-91.84%) | View |
| 2021-02-16 2:50 pm Purchase | 13G | COSCIENS Biopharma Inc. CSCI | ARMISTICE CAPITAL LLC | 2,808,930 4.990% | 1,595,192 (+131.43%) | View |
| 2021-02-12 4:46 pm Purchase | 13G | COSCIENS Biopharma Inc. CSCI | Lind Global Macro Fund LP | 4,421,512 7.600% | 329,623 (+8.06%) | View |
| 2021-01-29 06:39 am Purchase | 13G | COSCIENS Biopharma Inc. CSCI | INTRACOASTAL CAPITAL LLC | 3,553,781 5.400% | 1,331,559 (+59.92%) | View |
| 2020-07-10 06:11 am Purchase | 13G | COSCIENS Biopharma Inc. CSCI | INTRACOASTAL CAPITAL LLC | 2,222,222 5.100% | 2,222,222 (New Position) | View |
| 2020-07-07 4:04 pm Purchase | 13G | COSCIENS Biopharma Inc. CSCI | Lind Global Macro Fund LP | 4,091,889 9.900% | 4,091,889 (New Position) | View |
| 2020-02-28 5:18 pm Purchase | 13G | COSCIENS Biopharma Inc. CSCI | ARMISTICE CAPITAL LLC | 1,213,738 5.200% | 191,491 (+18.73%) | View |
| 2020-02-14 4:18 pm Sale | 13G | COSCIENS Biopharma Inc. CSCI | J. Goldman & Co LP | 0 0.000% | -997,494 (Position Closed) | View |
| 2020-01-23 3:03 pm Unchanged | 13G | COSCIENS Biopharma Inc. CSCI | Empery Asset Management LP | 1,661,000 4.990% | 0 (Unchanged) | View |